Overview
Kansas City Heart Rhythm Symposium
Registration is closed for this activity.
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trials that have helped change the clinical practice of EP will also be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage (LAA) treatment options and gain a greater understanding of anticoagulation and stroke prophylaxis.
Full refunds will only be given prior to August 12, 2016. Registration cancellation refunds will not be made after August 12 at 11:59 PM Central Time, and cancellations after this time will have a $30 administrative processing fee applied to the card on file.
Please note, Kansas University pre registrants may encounter difficulties when registering since a firewall prevents registration. In this case, please utilize a personal home computer.
Full refunds will only be given prior to August 12, 2016. Registration cancellation refunds will not be made after August 12 at 11:59 PM Central Time, and cancellations after this time will have a $30 administrative processing fee applied to the card on file.
Please note, Kansas University pre registrants may encounter difficulties when registering since a firewall prevents registration. In this case, please utilize a personal home computer.
This symposium is designed for physicians, advanced practice registered nurses, nurses and allied health professionals in the fields of electrophysiology, interventional cardiology, interventional radiology, and vascular surgery.
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trials that have helped change the clinical practice of EP will also be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage (LAA) treatment options and gain a greater understanding of anticoagulation and stroke prophylaxis.
Upon completion of this activity, participants will be able to:
• Discuss types of devices used for monitoring and treatment of arrhythmias
• Describe alternative therapies of treatment in patients with arrhythmias
• Discuss advances in ablative techniques for arrhythmias
• Demonstrate the use of imaging techniques to improve procedural outcomes
• Apply guideline-endorsed, clinically applicable strategies to help resolve lead failure,
device malfunctions, and other device-related issues
• Discuss how to improve safety and efficacy of electrophysiology (EP) procedures
• Summarize clinical trials that helped change clinical practice in the EP field
• Identify updates in heart failure treatment options
• Investigate the role that genetics has in patients with arrhythmias
• Explain anticoagulation treatment and stroke prophylaxis options for cardiac patients
• Examine clinical evidence for the latest trends in LAA treatments
• Discuss types of devices used for monitoring and treatment of arrhythmias
• Describe alternative therapies of treatment in patients with arrhythmias
• Discuss advances in ablative techniques for arrhythmias
• Demonstrate the use of imaging techniques to improve procedural outcomes
• Apply guideline-endorsed, clinically applicable strategies to help resolve lead failure,
device malfunctions, and other device-related issues
• Discuss how to improve safety and efficacy of electrophysiology (EP) procedures
• Summarize clinical trials that helped change clinical practice in the EP field
• Identify updates in heart failure treatment options
• Investigate the role that genetics has in patients with arrhythmias
• Explain anticoagulation treatment and stroke prophylaxis options for cardiac patients
• Examine clinical evidence for the latest trends in LAA treatments
Sheraton Kansas City Hotel at Crown Center
2345 McGee St
Kansas City, MO 64108 USA
Click here to view location map
Phone: (816) 841-1000
2345 McGee St
Kansas City, MO 64108 USA
Click here to view location map
Phone: (816) 841-1000
For additional details, please visit the conference website at www.kchrs.com.
REGISTRATION CANCELLATION POLICY:
Full refunds will only be given prior to August 12, 2016.
Registration cancellation refunds will not be made after August 12 at 11:59 PM Central Time, and cancellations after this time will have a $30 administrative processing fee applied to the card on file.
Full refunds will only be given prior to August 12, 2016.
Registration cancellation refunds will not be made after August 12 at 11:59 PM Central Time, and cancellations after this time will have a $30 administrative processing fee applied to the card on file.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and KCHRS Foundation. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credits™.
This activity has been approved for AMA PRA Category 1 Credits™.
Provider approved by the California Board of Registered Nursing, Provider Number 14803.